WPRIM Management System> DCMS> Acta Pharmaceutica Sinica> 2010> 45> 11

Volume: 45 Issue: 11

1. Drug release properties of sodium alginate hydrophobically modified by star polylactic acid. Page:1447—1451
2. Microemulsion-based gel of fluorouracil for transdermal delivery. Page:1440—1446
3. Effects of combination of Salvia miltiorrhiza and Panax notoginseng on the pharmacokinetics of their major bioactive components in Beagle dog. Page:1433—1439
4. Population pharmacokinetic modeling of flurbiprofen. Page:1427—1432
5. Feasibility of the extended application of near infrared universal quantitative models. Page:1421—1426
6. Isolation and identification of impurities from raw material of clindamycin phosphate. Page:1415—1420
7. Fingerprints of Tongmai Keli by HPLC-DAD-MS. Page:1410—1414
8. Elucidating the structure of two cyclotides of Viola tianshanica maxim by MALDI TOF/TOF MS analysis. Page:1402—1409
9. Isolation and identification of chemical constituents from Taxus cuspidta Sibe et Zucc. Page:1398—1401
10. Design, synthesis and in vitro activity of glycinamide-bearing compounds as DPP-IV inhibitors. Page:1379—1384
11. Intestinal absorption of forsythoside A by rat circulation in situ. Page:1373—1378
12. High-throughput screening of human soluble epoxide hydrolase inhibitors. Page:1367—1372
13. Glycosylation and L303e/F309S mutations improve intein-mediated splicing of the split coagulation factor VIII. Page:1361—1366
14. "Total amount" release kinetics evaluation of traditional Chinese medicine sustained-release preparations based on material rough set theory. Page:1354—1360
15. Advance in the study of poly(lactide-co-glycolide) nano/microparticles as gene vector. Page:1346—1353
16. Advances in the study of structural modifications and biological activities of betulinic acids. Page:1339—1345
17. Neurodegenerative conformational disease and heat shock proteins. Page:1333—1338
18. Combination of fenofibrate and rosiglitazone synergistically ameliorate dyslipidemia and insulin resistance in mice with MSG metabolic syndrome. Page:1459—1466
19. Impacts of bicyclo-monoterpene enhancers on transdermal delivery of ligustrazine. Page:1452—1458
20. Synthesis and LAR inhibition of 7-alkoxy analogues of illudalic acid. Page:1385—1397
21. Synthesis and LAR inhibition of 7-alkoxy analogues of illudalic acid. Page:1385—97
22. Impacts of bicyclo-monoterpene enhancers on transdermal delivery of ligustrazine. Page:1452—8
23. Combination of fenofibrate and rosiglitazone synergistically ameliorate dyslipidemia and insulin resistance in mice with MSG metabolic syndrome. Page:1459—66
24. Neurodegenerative conformational disease and heat shock proteins. Page:1333—8
25. Advances in the study of structural modifications and biological activities of betulinic acids. Page:1339—45
26. Advance in the study of poly(lactide-co-glycolide) nano/microparticles as gene vector. Page:1346—53
27. "Total amount" release kinetics evaluation of traditional Chinese medicine sustained-release preparations based on material rough set theory. Page:1354—60
28. Glycosylation and L303e/F309S mutations improve intein-mediated splicing of the split coagulation factor VIII. Page:1361—6
29. High-throughput screening of human soluble epoxide hydrolase inhibitors. Page:1367—72
30. Intestinal absorption of forsythoside A by rat circulation in situ. Page:1373—8
31. Design, synthesis and in vitro activity of glycinamide-bearing compounds as DPP-IV inhibitors. Page:1379—84
32. Isolation and identification of chemical constituents from Taxus cuspidta Sibe et Zucc. Page:1398—401
33. Population pharmacokinetic modeling of flurbiprofen. Page:1427—32
34. Elucidating the structure of two cyclotides of Viola tianshanica maxim by MALDI TOF/TOF MS analysis. Page:1402—9
35. Fingerprints of Tongmai Keli by HPLC-DAD-MS. Page:1410—4
36. Isolation and identification of impurities from raw material of clindamycin phosphate. Page:1415—20
37. Feasibility of the extended application of near infrared universal quantitative models. Page:1421—6
38. Effects of combination of Salvia miltiorrhiza and Panax notoginseng on the pharmacokinetics of their major bioactive components in Beagle dog. Page:1433—9
39. Microemulsion-based gel of fluorouracil for transdermal delivery. Page:1440—6
40. Drug release properties of sodium alginate hydrophobically modified by star polylactic acid. Page:1447—51